Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye-Tracking games may sharpen aging brains and lift mood

NCT ID NCT07690709

Completed Symptom relief Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether a computerized eye-tracking training program can improve mood and thinking skills in older adults who have memory complaints but no dementia. Participants aged 60 to 80 will do 18 sessions over about 1.5 months, focusing on tasks that require attention and impulse control. Researchers will compare their results to a waitlist group to see if the training reduces anxiety and depression and improves focus.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Eye-tracking training program
What this could lead to
If it works, this could offer a simple, non-drug way to ease anxiety and boost attention in older adults with memory worries.
What could go wrong
This is a small, early-stage trial with only 78 participants. The training is time-intensive (18 sessions), and benefits may not last or apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY SUBJECTIVE MEMORY COMPLAINTS

Contacts and locations

Locations

  • International Women's League Neighbourhood Elderly Centre

    Hong Kong, Hong Kong

  • Research Center for Neuropsychological Well-being

    Hong Kong, 0000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.